| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234018 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 8 Pages |
Abstract
The results of our study have shown that hypofractionated intensity-modulated arc radiotherapy as primary therapy for N1 prostate cancer is feasible with low toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Valérie M.D., Werner Ir., Ph.D., Wilfried M.D., Ph.D., Filip Ir., Ph.D., Nicolaas M.D., Katrien M.D., Geert M.D., Ph.D., Gert M.D., Ph.D.,